Bavarian Nordic A/S (CPH: BAVA)
Denmark
· Delayed Price · Currency is DKK | Market Cap | 20.70B |
| Revenue (ttm) | 6.08B |
| Net Income (ttm) | 707.42M |
| Shares Out | 77.83M |
| EPS (ttm) | 9.06 |
| PE Ratio | 29.35 |
| Forward PE | 15.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 678,383 |
| Open | 267.50 |
| Previous Close | 272.30 |
| Day's Range | 262.60 - 269.00 |
| 52-Week Range | 125.55 - 300.00 |
| Beta | 1.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 15, 2024 |
About Bavarian Nordic
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phas... [Read more]
Financial Performance
Financial StatementsNews
Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.
Bavarian Nordic’s Big Rally Just the Latest in Volatile History
This month’s near 50% rally in Bavarian Nordic A/S shares is nothing unusual for the Danish vaccine developer. But then again, neither are the falls that have often followed.
Singapore approves Bavarian's mpox vaccine Jynneos
Danish biotech Bavarian Nordic said on Tuesday its mpox vaccine Jynneos had been approved by Singapore's medicines regulatory authority for use in the country.
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore
COPENHAGEN, Denmark, August 27, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that Singapore's medicines regulatory authority, Health Sciences Authority (HSA), has approved JYNNEOS® (MVA-BN) ...
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Labcorp Holdings Inc (NYSE: LH) is reportedly collaborating with U.S. health regulators to determine whether it should scale up its mpox testing capabilities, following global concerns over a newly d...
Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy +
Discover 12 curated investment ideas on stocks with less coverage, including energy, healthcare, and M&A opportunities. Read what investors need to know.
Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy +
Discover 12 curated investment ideas on stocks with less coverage, including energy, healthcare, and M&A opportunities. Read what investors need to know.
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, August 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding man...
Danish pharma giant Bavarian Nordic secures deal for 440k mpox jabs
A Danish pharma giant with the only approved mpox jab in the US and Europe has done a deal to make 440,000 vaccines.
Mpox vaccine maker Bavarian Nordic’s stock jumps 10% as European country places jumbo order for doses
Second-quarter earnings beat estimates and company guides to top of full-year range
Bavarian Nordic A/S (BVNKF) Q2 2024 Earnings Call Transcript
Bavarian Nordic A/S (BVNKF) Q2 2024 Earnings Call Transcript
Bavarian Nordic A/S reports 1H results
Bavarian Nordic A/S reports 1H results
Bavarian Nordic shares rise on stronger earnings and Mpox vaccine order
The company recently received a 440,000 smallpox and Mpox vaccine dose contract from an unnamed European country.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2166303621-d531caf645fa40429f9df33c6ef6a3d1.jpg)
Bavarian Nordic Stock Jumps on Revenue Beat, Mpox Vaccine Order
Shares of Bavarian Nordic are surging 12% in Danish trading after the company with the only approved mpox vaccine in the U.S. and Europe posted a quarterly revenue beat and announced a huge vaccine or...
Mpox Vaccine Maker Bavarian Nordic Shares Soar Amid Concern Over Virus Outbreak
Shares of Danish biotech Bavarian Nordic surged on Thursday after the company reported strong earnings and a large order of its mpox vaccine, extending its gains this year as nations mobilize to comba...
Bavarian Nordic Shares Continue Higher
Shares in Bavarian Nordic surged after the Danish Mpox vaccine maker received a new order and reported earnings that beat expectations.
Bavarian Nordic shares pop over 12% on earnings beat, bumper mpox vaccine order
Shares of Danish biotech company Bavarian Nordic jumped in early deals Thursday after reporting first-half earnings and a bumper mpox vaccine order.
Bavarian Nordic Announces First Half 2024 Results
COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calenda...
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country
COPENHAGEN, Denmark, August 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract of 440,000 doses to supply its MVA-BN® smallpox/mpox vaccine to an undisclosed European c...
France to donate 100,000 mpox vaccines as nation prepares for outbreak at home
Last week the health agency of the African Union said 200,000 vaccines would be deployed across Africa, due to agreements with the EU and Danish drug company Bavarian Nordic.
Danish drug maker mulls mpox vaccine production ramp up
Danish biotech firm Bavarian Nordic could ramp up production of its mpox vaccine even before having orders lined up, based on the outcome of talks this week with the World Health Organisation, the com...
Bavarian Nordic will decide this week on mpox vaccine ramp up, CEO says
Danish biotech firm Bavarian Nordic is considering ramping up production of its mpox vaccine without having orders lined up, based on talks this week with the World Health Organisation, the company's ...
Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
The drugmaking industry was responsible for half of the economy’s expansion last year when Denmark was one of the fastest growing in western Europe.